IBDEI16A ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20997,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,20997,1,5,0)
 ;;=5^DM Type I w/o Complications
 ;;^UTILITY(U,$J,358.3,20997,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,20998,0)
 ;;=272.0^^133^1308^22
 ;;^UTILITY(U,$J,358.3,20998,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20998,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,20998,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,20998,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,20999,0)
 ;;=272.1^^133^1308^27
 ;;^UTILITY(U,$J,358.3,20999,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20999,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,20999,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,20999,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,21000,0)
 ;;=272.2^^133^1308^24
 ;;^UTILITY(U,$J,358.3,21000,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21000,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,21000,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,21000,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,21001,0)
 ;;=275.42^^133^1308^21
 ;;^UTILITY(U,$J,358.3,21001,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21001,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,21001,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,21001,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,21002,0)
 ;;=275.41^^133^1308^28
 ;;^UTILITY(U,$J,358.3,21002,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21002,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,21002,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,21002,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,21003,0)
 ;;=276.7^^133^1308^23
 ;;^UTILITY(U,$J,358.3,21003,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21003,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,21003,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,21003,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,21004,0)
 ;;=275.2^^133^1308^19
 ;;^UTILITY(U,$J,358.3,21004,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21004,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,21004,1,5,0)
 ;;=5^Hyper or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,21004,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,21005,0)
 ;;=276.0^^133^1308^25
 ;;^UTILITY(U,$J,358.3,21005,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21005,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,21005,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,21005,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,21006,0)
 ;;=276.1^^133^1308^31
 ;;^UTILITY(U,$J,358.3,21006,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21006,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,21006,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,21006,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,21007,0)
 ;;=275.3^^133^1308^20
 ;;^UTILITY(U,$J,358.3,21007,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21007,1,4,0)
 ;;=4^275.3
 ;;^UTILITY(U,$J,358.3,21007,1,5,0)
 ;;=5^Hyper or Hypophosphatemia
 ;;^UTILITY(U,$J,358.3,21007,2)
 ;;=^93796
 ;;^UTILITY(U,$J,358.3,21008,0)
 ;;=240.0^^133^1308^14
 ;;^UTILITY(U,$J,358.3,21008,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21008,1,4,0)
 ;;=4^240.0
 ;;^UTILITY(U,$J,358.3,21008,1,5,0)
 ;;=5^Goiter, Simple
 ;;^UTILITY(U,$J,358.3,21008,2)
 ;;=^259806
 ;;^UTILITY(U,$J,358.3,21009,0)
 ;;=241.1^^133^1308^13
 ;;^UTILITY(U,$J,358.3,21009,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21009,1,4,0)
 ;;=4^241.1
 ;;^UTILITY(U,$J,358.3,21009,1,5,0)
 ;;=5^Goiter, Nontox, Multinod
 ;;^UTILITY(U,$J,358.3,21009,2)
 ;;=^267790
 ;;^UTILITY(U,$J,358.3,21010,0)
 ;;=241.0^^133^1308^50
 ;;^UTILITY(U,$J,358.3,21010,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21010,1,4,0)
 ;;=4^241.0
 ;;^UTILITY(U,$J,358.3,21010,1,5,0)
 ;;=5^Thyroid Nodule, Nontoxic
 ;;^UTILITY(U,$J,358.3,21010,2)
 ;;=^83865
